| Target Price | £1.48 |
| Price | £0.99 |
| Potential |
49.31%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Stv Group 2027 .
The average Stv Group target price is £1.48.
This is
49.31%
register free of charge
£1.89
90.14%
register free of charge
£1.12
12.79%
register free of charge
|
|
| A rating was issued by 6 analysts: 5 Analysts recommend Stv Group to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Stv Group stock has an average upside potential 2027 of
49.31%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million £ | 176.90 | 159.53 |
| 5.90% | 9.82% | |
| EBITDA Margin | 9.50% | 11.40% |
| 15.38% | 20.04% | |
| Net Margin | -2.83% | 4.12% |
| 149.20% | 245.77% |
3 Analysts have issued a sales forecast Stv Group 2026 . The average Stv Group sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Stv Group EBITDA forecast 2026. The average Stv Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Stv Group Analysts have issued a net profit forecast 2026. The average Stv Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share £ | -0.11 | 0.14 |
| 147.83% | 227.27% | |
| P/E | 7.06 | |
| EV/Sales | 0.69 |
3 Analysts have issued a Stv Group forecast for earnings per share. The average Stv Group EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


